VMP1

Vacuole membrane protein 1 · Q96GC9 · VMP1 on Sugi Atlas →

0 patent compounds predicted against VMP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to VMP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer PHASE3COMPLETED
Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients PHASE3COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer PHASE1/PHASE2COMPLETED
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Pembrolizumab (MK-3475) in MM Patients With Residual Disease PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Nilotinib in Huntington's Disease PHASE1UNKNOWN
Autophagy Induction After Bortezomib for Myeloma EARLY_PHASE1COMPLETED
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction EARLY_PHASE1RECRUITING
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) nanWITHDRAWN
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo nanUNKNOWN
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. nanCOMPLETED
Effects of Trehalose and Polyphenols in Vasculopathic Patients nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Evaluation of Serum Autophagic Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Individuals nanENROLLING_BY_INVITATION
Periodontal Status and Endothelial Dysfunction in Patients With Polycystic Ovary Syndrome nanCOMPLETED
Time Course for Fasting-induced Autophagy in Humans nanWITHDRAWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Effect of Non-chirurgical Periodontal Treatment on the Immune System From a Gender Perspective nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Strong Evidence: Digitally Delivered Exercise in Older Adults nanACTIVE_NOT_RECRUITING
The Natural History of Alpha-Mannosidosis nanCOMPLETED
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a VMP1 binder may also engage these)

ProteinNameSimilarity
Q0VCK9 1.000 Q0VCK9 →
Q5R9K4 1.000 Q5R9K4 →
Q99KU0 1.000 Q99KU0 →
Q91ZQ0 1.000 Q91ZQ0 →
Q6INE8 0.997 Q6INE8 →
Q68EQ9 0.996 Q68EQ9 →
Q6NYY9 0.994 Q6NYY9 →
Q8BXA5 0.968 Q8BXA5 →
A2VE61 0.966 A2VE61 →
E1BD52 0.962 E1BD52 →
Q5ZKJ0 0.962 Q5ZKJ0 →
ZMPSTE24 CAAX prenyl protease 1 homolog 0.962 landscape →
A9JRA0 0.961 A9JRA0 →
D3ZXD8 0.960 D3ZXD8 →
Q9QZ71 0.960 Q9QZ71 →
Q8WVP7 0.960 Q8WVP7 →
Q940S0 0.960 Q940S0 →
Q9TU72 0.959 Q9TU72 →
Q9JIT0 0.958 Q9JIT0 →
Q28CY9 0.958 Q28CY9 →
B1AZA5 0.958 B1AZA5 →
Q9H330 0.958 Q9H330 →
Q6DD32 0.958 Q6DD32 →
CLPTM1L Lipid scramblase CLPTM1L 0.958 landscape →
A3KN28 0.958 A3KN28 →
Q5R7B1 0.957 Q5R7B1 →
CDS2 Phosphatidate cytidylyltransferase 2 0.957 landscape →
Q9Z0U0 0.956 Q9Z0U0 →
Q99L43 0.956 Q99L43 →
Q9QZ70 0.956 Q9QZ70 →